Internal Medicine News - Short-course Levaquin approved.(PRODUCTS)(Brief Article)
The Food and Drug Administration approved a 5-day course of Levaquin (levofloxacin) with 750-mg once-daily tablets to treat adults with acute bacterial sinusitis caused …
Related Results
WASHINGTON INSIDER: Update
Levaquin[R] receives FDA approval for treatment of chronic bacterial prostati…
Short-course Levaquin approved.(PRODUCTS)(Brief Article)
FDA grants approval for new oral solution of Levaquin
Pipeline
Read the rest of this article with a Free Trial at HighBeam Research.
